Diagnosis and grade
Biopsy pathology, Gleason score/Grade Group and number of positive cores are reviewed.
Oncology evaluation directory
Urologic oncology
Prostate Cancer Evaluation
A urologic-oncology review for prostate cancer, built around PSA trend, biopsy grade group, imaging stage, hormone sensitivity, prior systemic therapy, bone symptoms and current treatment objective.
Medical disclaimer: This page is informational and coordination-focused. It does not diagnose, prescribe, promise treatment suitability or replace urgent local medical care.
Clinical file logic
What the specialist needs to understand before any treatment discussion.
Prostate cancer can range from localized disease to metastatic castration-resistant disease. The review must therefore include grade, PSA trend, imaging and the current hormonal/systemic therapy status rather than a simple diagnosis label.
The file is prepared so the physician can see whether the question is active surveillance, post-surgery recurrence, metastatic hormone-sensitive disease, castration-resistant progression or symptom control.
PSA timeline
PSA values before and after treatment are placed in chronological order.
Current stage
MRI prostate, PSMA PET, bone scan, CT or other imaging documents local, nodal and bone disease.
Hormonal status
ADT use, testosterone level when available and castration-sensitive/resistant status are clarified.
Prior treatments
Surgery, radiation, ADT, AR inhibitors, chemotherapy, radioligand therapy or bone agents are summarized.
Symptoms and bone risk
Bone pain, fractures, spinal symptoms, urinary obstruction and performance status are included.
Evaluation matrix
How the case is reviewed without reducing it to a diagnosis name.
Each item below affects how the file is interpreted, what the physician can answer and whether additional documents are needed before a responsible response.
PSA alone is not enough
PSA must be interpreted with pathology, imaging and treatment context.
Castration status
Whether progression occurs despite low testosterone changes the review question.
Bone disease safety
Spinal pain or neurological symptoms require urgent local evaluation.
Treatment sequencing
Prior ADT, AR inhibitors and chemotherapy affect next-step discussions.
Documents to prepare
A complete medical file prevents delay and unrealistic expectations.
Most delays happen when the diagnosis is described verbally but the file lacks dates, reports, imaging, pathology or the current specialist recommendation. The documents below are requested before the file is considered ready for review.
Cuba context
How Cuba-related options are framed responsibly.
The page does not present a hospital visit or travel plan as automatically suitable. Any Cuba-related discussion remains conditional on physician review of the current file.
Disease state is defined first
Localized recurrence and metastatic resistant disease require different routing.
Symptoms are not ignored
Pain, urinary blockage and spinal risks are part of coordination.
Physician-led decisions
CHA does not replace oncology/urology decisions; it structures the case for review.
Cuba context and clinical priority
Prostate cancer: what has to be clear first
No Cuba-related option takes precedence over proven standard treatment.
Decisions in prostate cancer follow the PSA trajectory, biopsy grade group (Gleason/ISUP), imaging stage, and the patient's age and comorbidities. Active surveillance is a valid option in low-risk disease; in advanced disease, hormone sensitivity determines the treatment sequence. PSMA PET has become increasingly decisive in demonstrating spread.
Cuba-related products have been studied in specific tumour types and are licensed in Cuba within their own approved indications. In this diagnosis the real contribution of an international review is to re-examine the current plan, check whether an option has been missed, and identify what is missing from the file. That is only possible with a complete and current record.
The file should therefore contain the full pathology report, staging imaging, a list of treatments given with dates and doses, current blood tests and the most recent oncology consultation note. An incomplete file causes both misdirection and avoidable delay.
Pathology and stage
Grade group (ISUP), PSA values with dates, and bone or PSMA imaging results should appear in the report.
Molecular markers
Hormone sensitivity and any genetic testing (for example BRCA) change treatment in advanced disease.
Treatment history
Previous surgery, radiotherapy and hormone therapy with durations, together with bone-protective treatment, should be listed.
When local care comes first
Do not wait for international review if urgent symptoms are present.
International coordination should never delay emergency care. If any of the following are present, the patient should be assessed locally first.
- New leg weakness, numbness, bladder/bowel changes or severe back pain.
- Urinary retention, kidney obstruction or fever with urinary infection.
- Severe uncontrolled bone pain or suspected fracture.
Coordination pathway
From records to written next steps.
- File intakeReports, imaging, summaries and current symptoms are uploaded through the application flow.
- Quality checkThe coordination team checks readability, dates, translation needs and missing items.
- Specialist routingThe case is prepared around a clear medical question and routed to the relevant review pathway.
- Written responseThe patient receives an organized next-step explanation before travel, payment or treatment logistics are considered.
Questions
Before starting the application.
Does this page mean I am suitable for a Cuba-based treatment?
No. It explains how the file is organized for review. Suitability, route, timing and safety can only be determined by physicians after reviewing the complete current record.
Can I send only a short summary?
A summary helps, but it is not enough for most oncology reviews. Pathology, imaging, treatment history, lab results and the latest oncology note are usually needed.
Will the coordinator choose my treatment?
No. Cuba Health Assist coordinates records, communication, translation support and logistics. Medical decisions remain with licensed physicians and the patient’s treating team.
What happens if my file is incomplete?
The team will request missing reports before presenting the case as ready. This protects the patient from receiving a weak or unrealistic response.
Can urgent symptoms be handled through this page?
No. Severe or rapidly worsening symptoms require local emergency or oncology care first. International coordination is not an emergency service.
Related evaluation pages
Other oncology files reviewed in the same clinical directory.
Start with the file
Submit documents before making a travel or treatment decision.
A coordinator will organize the medical information and guide the next step according to specialist review. The process is designed to be transparent, clinically cautious and written.